The North America swabs collection kit market is expected to grow from US$ 1,513.73 million in 2021 to US$ 2,087.85 million by 2028. It is estimated to grow at a CAGR of 4.7% from 2021 to 2028.
North America has witnessed a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, as of November 27, 2020, the number of cases increased to 13,248,676, with 269,555 deaths reported in the US. The cases are also increasing in Mexico and Canada. In Mexico, COVID had reached 1,078,594 with 104,242 deaths. Similarly, there were about 353,097 COVID-19 cases in Canada, with 11,799 reported deaths. Samples are taken from places likely to have high virus concentration, i.e., from the back of the nose or mouth or through a bronchoalveolar lavage. Thus, swab collection is a vital step in effectively diagnosing an active infection of the novel coronavirus in the body. The Center for Disease Control and Prevention (CDC) and the US Food and Drug Administration (USFDA) have established standard methods and recommendations for manufacturers to create COVID-19 sample collection and transport kits. With the rising number of hospitals expanding their testing capabilities, the demand for swab collection kits is escalating across North America.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America swabs collection kit market at a good CAGR during the forecast period.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Lucence Diagnostics; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc.; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; QIAGEN; and Path-Tec, LLC by Altair are the leading companies in the regional market.
North America has witnessed a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, as of November 27, 2020, the number of cases increased to 13,248,676, with 269,555 deaths reported in the US. The cases are also increasing in Mexico and Canada. In Mexico, COVID had reached 1,078,594 with 104,242 deaths. Similarly, there were about 353,097 COVID-19 cases in Canada, with 11,799 reported deaths. Samples are taken from places likely to have high virus concentration, i.e., from the back of the nose or mouth or through a bronchoalveolar lavage. Thus, swab collection is a vital step in effectively diagnosing an active infection of the novel coronavirus in the body. The Center for Disease Control and Prevention (CDC) and the US Food and Drug Administration (USFDA) have established standard methods and recommendations for manufacturers to create COVID-19 sample collection and transport kits. With the rising number of hospitals expanding their testing capabilities, the demand for swab collection kits is escalating across North America.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America swabs collection kit market at a good CAGR during the forecast period.
North America swabs collection kit Market Segmentation
The North America swabs collection kit market is analyzed on the basis of type, application, and country. Based on type, the market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the market in 2020. Based on application, the market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the market in 2020. Based on country, the North America swabs collection kit market is segmented into the US, Canada, and Mexico. The US dominated the market in 2020.BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Lucence Diagnostics; Quidel Corporation; DiaSorin S.P.A; Copan Italia SPA; Norgen Biotek Corp; Hologic, Inc.; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; QIAGEN; and Path-Tec, LLC by Altair are the leading companies in the regional market.
Table of Contents
1. Introduction
3. Research Methodology
4. North America Swabs Collection Kit Market- Market Landscape
5. North America Swabs Collection Kit Market - Key Market Dynamics
6. Swabs Collection Kit Market- North America Analysis
7. North America Swabs Collection Kits Market Analysis - By Type
8. North America Swabs Collection Kits Market Analysis - By Application
9. North America Swabs Collection Kit Market - Country Analysis
10. Industry Landscape
11. Company Profiles
12. Appendix
List of Figures
List of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BD
- Puritan Medical Products Company LLC
- Laboratory Corporation of America Holdings
- HiMedia Laboratories
- THERMO FISHER SCIENTIFIC INC.
- Hardy Diagnostics
- VIRCELL S.L
- BTNX, Inc
- Formlabs
- Lucence Diagnostics
- Quidel Corporation
- DiaSorin S.P.A
- Copan Italia S.P.A
- Norgen Biotek Corp
- Hologic, Inc
- Quest Diagnostics Incorporated
- Abbott
- Lynn Peavey Company
- QIAGEN
- Path-Tec, LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 154 |
| Published | July 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1513.73 Million |
| Forecasted Market Value ( USD | $ 2087.85 Million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | North America |
